Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
MediKarma Acquires Nanell from Niterra Co., Ltd. to Accelerate Women’s Health Expansion and Value-Based Care Footprint
Strategic Move Integrates Specialized Pregnancy Journey Solution into MediKarma’s Holistic Patient Profile, Deepening B2B2C Engagement
MediKarma, the AI-driven platform that unifies and activates patient data to drive proactive care, today announced it has successfully completed the acquisition of Nanell, a specialized digital solution focused on the pregnancy journey, from Niterra Co., Ltd (Headquarters: Nagoya, Japan). The acquisition is set to integrate Nanell’s intellectual property, product assets and operations directly into MediKarma’s platform, strengthening its offering in Women’s Health.
Nanell was created by Niterra Ventures Company of Niterra Co., Ltd. to provide expert consultation, guided resources and health tracking, and has reported strong early results including targeted support for first-time and high-risk pregnancies, with retention above category averages.
“This acquisition immediately fast-tracks MediKarma’s expansion into women’s health with a solution purpose-built for the critical moments that happen between visits,” said Kris Narayan, CEO at MediKarma. “By integrating Nanell’s proven pregnancy expertise, we empower our members with clearer, real-time guidance and route meaningful signals back to care teams. This is a strategic move that strengthens value for payors and employers by offering earlier risk visibility and delivers a more human, proactive experience for families at a pivotal life stage.”
Under the agreement, MediKarma acquires Nanell‘s IP and related assets, followed by a planned 60–90 day knowledge transfer and operational transition. The commercial structure includes equity-linked consideration and a revenue-share component aligned to Nanell’s future growth. Furthermore, the collaboration is cemented by Niterra Ventures Company’s commitment to provide transitional support.
“Niterra Co., Ltd. invests and, in the past, also built ventures with the vision to improve everyone’s quality of life. Nanell was the result of researching women’s needs and building a solution for better support during pregnancy,” said Dirk Schapeler, President at Niterra Ventures Company of Niterra Co., Ltd…
Full release here, originally announced February 23rd, 2026.
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
Eucalyptus is a Consumer Healthcare Leader in Australia, the UK and Germany, with Expanding New Operations in Japan and Canada
Hims & Hers Health, Inc., the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company’s ability to bring access to high-quality, personalized care to more people across the world. As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. The terms of the transaction have been structured to preserve the financial flexibility of the company, ensuring continued control over balance sheet management and capital allocation.
With this acquisition, Hims & Hers plans to expand its bench of local expertise and scale its infrastructure, making it possible for the company to reach millions more people globally with the model it has successfully built – and continues to maintain – in the US. Hims & Hers is committed to partnering with regional experts to enter new markets in a way that meets each region’s needs and supports customer access and choice. Together with Hims & Hers’ other recent acquisitions, the addition of Eucalyptus will create a diversified international platform that expands the range of offerings available to customers around the world, from simple online pharmacy fulfillment to advanced, concierge-style service.
“Healthcare challenges are global, and so is the demand for simpler, transparent, and more personalized healthcare. But how that comes to life looks different for every region and every person. We’ve shown the difference that makes in the US, and the logical next step is working with more international experts to make that difference abroad,” said Andrew Dudum, Founder and CEO at Hims & Hers. “With Eucalyptus, we will not only enter new markets, we will expand our ability to serve customers globally, trusting local experts to be a key part of how we transform healthcare into a customer-first, personalized industry. We believe this puts us on the path to becoming the leading global consumer health platform, where everyone can access the best care for their needs, regardless of where they live.”
Eucalyptus operates several consumer-beloved brands across the world – including Juniper and Pilot – and has served more than 775,000 customers. Eucalyptus has a demonstrated track record of efficiently entering new markets and is recognized for its customer-first approach, clinical rigor, simple digital experience, and local regulatory expertise. The company has also published more than 20 peer-reviewed articles in international journals, examining how its model supports patient outcomes, adherence, quality and safety. It is also the first Australian telehealth business to receive accreditation from the Australian Council on Healthcare Standards (ACHS).
Following the completion of the acquisition, Tim Doyle, current CEO at Eucalyptus, will become the SVP of International at Hims & Hers, overseeing the company’s international business…
Full release here, originally announced February 19th, 2026.
No comments:
Post a Comment